Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)
Clinical trial NCT03949634 · UNKNOWN
Trial details
- NCT number
- NCT03949634
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2019-10-31
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.